STUDY DESIGN AND RATIONALE OF EXPLORER-CN: A PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAVACAMTEN IN CHINESE ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy

Introduction Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease commonly caused by pathogenic genetic variants encoding sarcomere proteins.Mavacamten, a first-in-class allosteric inhibitor of cardiac-specific myosin, has demonstrated efficacy and safety in international clinical trials of patients with symptomatic obstructive HCM (oH

read more


Occurrence and mineralogy of the margarite- and muscovite-bearing pseudomorphs after topaz in the Juurakko pegmatite, Orivesi, southern Finland

Margarite- and muscovite-bearing pseudomorphs after topaz are described from the Juurakko pegmatite dyke, Orivesi, southern Finland.A supercritical vapour phase rich in calcium and alkalies caused alteration of topaz and some other silicates during final phase of crystallization of the dyke.The original columnar form of topaz crystals is characteri

read more